
    
      GLS-5300 is a DNA plasmid vaccine that expresses the MERS CoV spike (S) glycoprotein.
      Following administration of the vaccine, a specialized medical device, CELLECTRAÂ®, will
      deliver brief electrical pulses in a process known as electroporation (EP), to help move DNA
      into cells more efficiently.
    
  